Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

ClinicalTrials.gov ID: NCT01872689

Public ClinicalTrials.gov record NCT01872689. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, multicenter, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of lebrikizumab as monotherapy in the absence of background IPF therapy and as combination therapy with pirfenidone background therapy in participants with IPF. Participants will be randomized to receive either lebrikizumab or placebo subcutaneously every 4 weeks.

Study identification

NCT ID
NCT01872689
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
505 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 13, 2013 (Actual)
Primary completion
Jul 28, 2017 (Actual)
Completion
Nov 6, 2017 (Actual)
Last update posted
Aug 24, 2018

2013 – 2017

United States locations

U.S. sites
54
U.S. states
31
U.S. cities
50
Facility City State ZIP Site status
University Alabama At Birmingham Birmingham Alabama 35294 —
Mayo Clinic- Scottsdale Scottsdale Arizona 85259 —
Southern Arizona Veterans Administration Healthcare Systems Tucson Arizona 85723 —
University of Arizona Tucson Arizona 85724-5030 —
UCSD Medical Center La Jolla California 92093 —
University of California, San Francisco San Francisco California 94116 —
National Jewish Health Denver Colorado 80206 —
Rocky Mountain Center For Clinical Research Wheat Ridge Colorado 80033 —
Yale New Haven Hospital New Haven Connecticut 06520 —
Research Alliance Inc Clearwater Florida 33756 —
Mayo Clinic-Jacksonville Jacksonville Florida 32224 —
University Miami Miami Florida 33136 —
Central Florida Pulmonary Group, PA Orlando Florida 32803 —
USF Tampa General Hospital Tampa Florida 33606 —
Cleveland Clinic Florida Weston Florida 33331 —
Piedmont Healthcare Pulmonary and Critical Care Research Austell Georgia 30106 —
Southeastern Lung Care Decatur Georgia 30033 —
University of Chicago; Pulmonary and Critical Care Chicago Illinois 60637 —
Loyola University Med Center Maywood Illinois 60153 —
Univ of Iowa Hosp & Clinics; Pulmonary Iowa City Iowa 52242 —
Uni of Kansas Medical Center Kansas City Kansas 66160 —
Via Christi Hospital Inc. DBA Via Christi Research; Research Dept. Wichita Kansas 67208 —
Maine Medical Center -Division of Pulmomary and Critical Care Medicine Portland Maine 04106 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Johns Hopkins Bayview Medical Center - Johns Hopkins Asthma & Allergy Center Baltimore Maryland 21224 —
Tufts Medical Center Boston Massachusetts 02111 —
University of Minnesota Hospital & Clinic Minneapolis Minnesota 55455 —
Mayo Clinic Rochester Rochester Minnesota 55902 —
Cardiopulmonary Associates LLC Cardiopulmonary Research Chesterfield Missouri 63017 —
University of Nebraska Omaha Nebraska 68198-5300 —
Lovelace Scientific Resources, Inc. Albuquerque New Mexico 87108 —
Weill Medical College of Cornell University New York New York 10021-5663 —
Mt Sinai School Medical Pulmo And Critical Care Med New York New York 10029 —
Highland Hospital-University of Rochester Medical Center Rochester New York 14620 —
University of Cincinnati Cincinnati Ohio 45203-0542 —
Case Western Research University; University Hospitals Case Medical Center Cleveland Ohio 44106-5067 —
Ohio State University Columbus Ohio 43210 —
Oklahoma University Health Sciences Center Oklahoma City Oklahoma 73104 —
The Oregon Clinic. Portland Oregon 97220 —
Penn State University College Medical Allergy And Care Med Hershey Pennsylvania 17033 —
Temple Lung Center, Temple Universtiy-Of the Commomwealth System of Higher Education Philadelphia Pennsylvania 19140 —
University of Pittsburgh Med Cen; Dorothy P And Richard P Simmons Cen For Interstitial Lung Disease Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital Providence Rhode Island 02903 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Baylor College Med Houston Texas 77030 —
Houston Methodist Hospital Houston Texas 77030 —
Audie Murphy Va Hospital San Antonio Texas 78229 —
University of Utah Health Sciences Center, Lung Health Research Center Salt Lake City Utah 84108 —
University Vermont College Medicine Fletcher Allen Health Care Colchester Vermont 05446 —
Inova Transplant Center Fairfax Hospital Falls Church Virginia 22042 —
Pulmonary Consultants Tacoma Washington 98405 —
University Wisconsin Hospitals and Clinics Madison Wisconsin 53792 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01872689, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01872689 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →